Literature DB >> 25129690

Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.

Paula J P de Vree1, Elzo de Wit2, Mehmet Yilmaz3, Monique van de Heijning3, Petra Klous3, Marjon J A M Verstegen4, Yi Wan4, Hans Teunissen4, Peter H L Krijger4, Geert Geeven4, Paul P Eijk5, Daoud Sie5, Bauke Ylstra5, Lorette O M Hulsman6, Marieke F van Dooren6, Laura J C M van Zutven6, Ans van den Ouweland6, Sjef Verbeek7, Ko Willems van Dijk7, Marion Cornelissen8, Atze T Das8, Ben Berkhout8, Birgit Sikkema-Raddatz9, Eva van den Berg9, Pieter van der Vlies9, Desiree Weening9, Johan T den Dunnen10, Magdalena Matusiak11, Mohamed Lamkanfi11, Marjolijn J L Ligtenberg12, Petra ter Brugge13, Jos Jonkers13, John A Foekens14, John W Martens14, Rob van der Luijt15, Hans Kristian Ploos van Amstel15, Max van Min3, Erik Splinter3, Wouter de Laat16.   

Abstract

Despite developments in targeted gene sequencing and whole-genome analysis techniques, the robust detection of all genetic variation, including structural variants, in and around genes of interest and in an allele-specific manner remains a challenge. Here we present targeted locus amplification (TLA), a strategy to selectively amplify and sequence entire genes on the basis of the crosslinking of physically proximal sequences. We show that, unlike other targeted re-sequencing methods, TLA works without detailed prior locus information, as one or a few primer pairs are sufficient for sequencing tens to hundreds of kilobases of surrounding DNA. This enables robust detection of single nucleotide variants, structural variants and gene fusions in clinically relevant genes, including BRCA1 and BRCA2, and enables haplotyping. We show that TLA can also be used to uncover insertion sites and sequences of integrated transgenes and viruses. TLA therefore promises to be a useful method in genetic research and diagnostics when comprehensive or allele-specific genetic information is needed.

Entities:  

Mesh:

Year:  2014        PMID: 25129690     DOI: 10.1038/nbt.2959

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  39 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Target-enrichment strategies for next-generation sequencing.

Authors:  Lira Mamanova; Alison J Coffey; Carol E Scott; Iwanka Kozarewa; Emily H Turner; Akash Kumar; Eleanor Howard; Jay Shendure; Daniel J Turner
Journal:  Nat Methods       Date:  2010-02       Impact factor: 28.547

Review 3.  Enrichment of target sequences for next-generation sequencing applications in research and diagnostics.

Authors:  Janine Altmüller; Birgit S Budde; Peter Nürnberg
Journal:  Biol Chem       Date:  2014-02       Impact factor: 3.915

4.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

5.  Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.

Authors:  A M van den Maagdenberg; M H Hofker; P J Krimpenfort; I de Bruijn; B van Vlijmen; H van der Boom; L M Havekes; R R Frants
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

Review 6.  Molecular genetic testing and the future of clinical genomics.

Authors:  Sara Huston Katsanis; Nicholas Katsanis
Journal:  Nat Rev Genet       Date:  2013-06       Impact factor: 53.242

7.  Three-dimensional maps of all chromosomes in human male fibroblast nuclei and prometaphase rosettes.

Authors:  Andreas Bolzer; Gregor Kreth; Irina Solovei; Daniela Koehler; Kaan Saracoglu; Christine Fauth; Stefan Müller; Roland Eils; Christoph Cremer; Michael R Speicher; Thomas Cremer
Journal:  PLoS Biol       Date:  2005-04-26       Impact factor: 8.029

8.  The MLL recombinome of acute leukemias in 2013.

Authors:  C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

Review 9.  Long-range control of gene expression: emerging mechanisms and disruption in disease.

Authors:  Dirk A Kleinjan; Veronica van Heyningen
Journal:  Am J Hum Genet       Date:  2004-11-17       Impact factor: 11.025

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  92 in total

1.  Transgenic animals and genetic engineering techniques. Nantes, France, 2-3 July, 2015.

Authors:  Séverine Ménoret; Laurent Tesson; Séverine Remy; Claire Usal; Laure-Hélène Ouisse; Lucas Brusselle; Vanessa Chenouard; Tuan H Nguyen; Laurent David; Ignacio Anegon
Journal:  Transgenic Res       Date:  2015-09-10       Impact factor: 2.788

2.  PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages.

Authors:  Sreedevi Avasarala; Pei-Ying Wu; Samia Q Khan; Su Yanlin; Michelle Van Scoyk; Jianqiang Bao; Alessandra Di Lorenzo; Odile David; Mark T Bedford; Vineet Gupta; Robert A Winn; Rama Kamesh Bikkavilli
Journal:  Mol Cancer Res       Date:  2019-10-16       Impact factor: 5.852

Review 3.  Haplotype-resolved genome sequencing: experimental methods and applications.

Authors:  Matthew W Snyder; Andrew Adey; Jacob O Kitzman; Jay Shendure
Journal:  Nat Rev Genet       Date:  2015-05-07       Impact factor: 53.242

4.  Guidelines for cytogenetic investigations in tumours.

Authors:  Rosalind J Hastings; Nick Bown; Maria G Tibiletti; Maria Debiec-Rychter; Roberta Vanni; Blanca Espinet; Nadine van Roy; Paul Roberts; Eva van den Berg-de-Ruiter; Alain Bernheim; Jacqueline Schoumans; Steve Chatters; Zuzana Zemanova; Marian Stevens-Kroef; Annet Simons; Sverre Heim; Marta Salido; Bauke Ylstra; David R Betts
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

Review 5.  Regulation of disease-associated gene expression in the 3D genome.

Authors:  Peter Hugo Lodewijk Krijger; Wouter de Laat
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-09       Impact factor: 94.444

6.  Gathering by the Red Sea highlights links between environment and epigenetics.

Authors:  Mo Li; Emiliana Borrelli; Pierre J Magistretti; Juan Carlos Izpisua Belmonte; Paolo Sassone-Corsi; Valerio Orlando
Journal:  Nat Struct Mol Biol       Date:  2017-06-06       Impact factor: 15.369

7.  Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing.

Authors:  Dörte Wren; Brian A Walker; Monika Brüggemann; Mark A Catherwood; Christiane Pott; Kostas Stamatopoulos; Anton W Langerak; David Gonzalez
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

8.  Novel microdeletions on chromosome 14q32.2 suggest a potential role for non-coding RNAs in Kagami-Ogata syndrome.

Authors:  Ilse M van der Werf; Karin Buiting; Christina Czeschik; Edwin Reyniers; Geert Vandeweyer; Piet Vanhaesebrouck; Hermann-Josef Lüdecke; Dagmar Wieczorek; Bernhard Horsthemke; Geert Mortier; Jules G Leroy; R Frank Kooy
Journal:  Eur J Hum Genet       Date:  2016-07-13       Impact factor: 4.246

Review 9.  Genome-wide mapping and analysis of chromosome architecture.

Authors:  Anthony D Schmitt; Ming Hu; Bing Ren
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-01       Impact factor: 94.444

10.  Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.

Authors:  Renate De Smedt; Sofie Peirs; Julie Morscio; Filip Matthijssens; Juliette Roels; Lindy Reunes; Beatrice Lintermans; Steven Goossens; Tim Lammens; Nadine Van Roy; Aurore Touzart; Silvia Jenni; Yi-Chien Tsai; Federica Lovisa; Lara Mussolin; Valentina Serafin; Filip Van Nieuwerburgh; Dieter Deforce; Anne Uyttebroeck; Thomas Tousseyn; Birgit Burkhardt; Wolfram Klapper; Barbara De Moerloose; Yves Benoit; Elizabeth Macintyre; Jean-Pierre Bourquin; Giuseppe Basso; Benedetta Accordi; Beat Bornhauser; Jules Meijerink; Peter Vandenberghe; Pieter Van Vlierberghe
Journal:  Haematologica       Date:  2018-08-03       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.